diabetestalk.net

Meet The Cycling Team That Runs On TUEs To Beat Diabetes

Meet the cycling team that runs on TUEs to beat diabetes

Meet the cycling team that runs on TUEs to beat diabetes

“It is pretty simple,” says Stephen Clancy, in a voice so soft one fears it might shatter. “We don’t abuse TUEs. We don’t get performance gains. For us it is literally a matter of life or death: if we don’t take them we will die. And I think it would be unfair if someone said I shouldn’t be granted one for a lifelong condition.” He pauses, collects his thoughts and tugs another heartstring. “And aside from health reasons, you are going to tear away someone’s dreams.”
The subject is therapeutic use exemptions (TUEs)– certificates that allow athletes to use medication on the World Anti-Doping Agency’s prohibited substances list because of an illness or condition – and whether they should be restricted or even banned. It is an issue that was blasted into the mainstream in September when the Russian hackers Fancy Bears published details of private TUEs of dozens of Olympic competitors. And it is one that appears likely to flare up again, given that Fancy Bears is promising more revelations and Team Sky’s Dave Brailsford is due to appear in parliament next month to answer why Bradley Wiggins received TUEs for triamcinolone – a substance which has a history of abuse in cycling and is otherwise banned – on the eve of the Tour de France in 2011 and 2012 and the Giro d’Italia in 2013.
Yet Clancy, a bright and amiable 24-year-old professional cyclist from Limerick, makes a passionate and persuasive case for why TUEs are absolutely necessary. For he, along with every rider in the Team Novo Nordisk cycling squad, has Type 1 diabetes. And without a TU Continue reading

Rate this article
Total 1 ratings
What Big Pharma is Afraid Diabetes Patients Will Find Out

What Big Pharma is Afraid Diabetes Patients Will Find Out

If you are a diabetes patient, you are Big Pharma’s best friend. You have been ear-marked for the rest of your life as a cash cow for the companies who make diabetes medicines, syringes, blood sugar monitors, insulin, cotton swabs, and more. But there is a little secret that the pharmaceutical companies don’t want you to know.
You don’t need to be one of the 15 million people in the US with this disease. Up to 90% of all diabetes type 2 (also called adult onset or non-insulin dependent diabetes) is caused by poor diet, lack of physical fitness, and lifestyle choices. You can “cure” yourself.
So, instead of spending your best years paying the pharmaceutical companies instead of for your dream vacation or a new car, or being put on ‘pre-diabetic’ drugs by your doctor before you ever attempt to lose a few pounds and change your eating habits to healthier ones, you can forge a new path to be diabetes-free.
Don’t allow Big Pharma to use you to inflate their stock holdings. In a popular pharmacy magazine, there was recently a slick, full-color, 4-page advertisement that said “The Diabetes Consumer: Shops More. Spends More. Shops the Whole Store.” Its disgusting the lengths these companies will go to in order to keep their profits high while caring so little about your health.
Read: Grape Seed Extract Superior to Anti-Diabetes Drug
Tips for Eliminating Type 2 Diabetes
Here are some simple steps you can take to stop diabetes type 2 in its tracks and keep the Big Pharma goons from taking your life and life’s blood:
1. Exercise at least 30 minutes a day, six day Continue reading

A Common Diabetes Drug Will Be Trialled as an Anti-Ageing Elixir From Next Year

A Common Diabetes Drug Will Be Trialled as an Anti-Ageing Elixir From Next Year

We all want to live healthier for longer, but despite the increase in lifespans over the past century, at some point, age inevitably catches up with us and our cells begin to make mistakes, leading to a range of diseases such as cancer and dementia. But now researchers believe they might have found something that could slow down the ageing process entirely – a cheap diabetes drug that's already being taken by millions of people.
Known as metformin, the drug has been on the market for around 60 years. But the reason scientists are so interested in it now is that, over that time, researchers have observed that the drug appears to reduce the likelihood of age-related cancers. Studies have also shown that diabetics taking metformin live longer than people who don't have diabetes – despite the fact that the condition normally takes eight years off people's lives.
"People on metformin get 30 percent less cancers, almost every cancer except maybe prostate cancer. There are fewer studies, but there is a signal that metformin prevents cognitive decline," co-leader of the study Nir Barzilai, from the Albert Einstein College of Medicine, told Andrea Alfano from Tech Times. "Additionally, there is a study that suggests that people on metformin who, when they start taking metformin, are more obese and sicker than people without diabetes, they outlive people without diabetes."
Based on these observations, the Food and Drug Administration (FDA) has now green-lit the drug to be trialled for its anti-ageing properties as early as next year. And if it ends up being approved, it'll be the Continue reading

Virgin Coconut Oil Effective in Treating Diabetes

Virgin Coconut Oil Effective in Treating Diabetes

Share
Share
Share
Editor, Health Impact News
Indeed Virgin Coconut Oil has a substantial effect on blood sugar levels. My wife and daughter (both have type 2 diabetes) measure their blood sugar levels at least three times a day. When they eat the wrong foods and their blood sugar levels get to 80-100 points above normal, they don’t take extra medication, they take 2-3 tablespoons of the coconut oil directly from the bottle. Within a half hour their blood sugar levels will come back to normal. Ed Coconut Diet Forums
25.8 million children and adults in the United States, 8.3% of the population, have diabetes.1 The current rate of people becoming diabetic in the United states is doubling every 10 years. This has resulted in a windfall for pharmaceutical companies capitalizing on this “disease” with drugs designed to treat type 2 diabetes, but not deal with the underlying cause. These drugs have serious side effects.
One of the most popular diabetes drugs, Avandia, was pulled off the market in 2011 after a number of studies showed that the drug increased the risk of heart attacks among type 2 diabetes patients. The manufacturer of the drug reached a $3 billion settlement in December 2011 over its fraudulent marketing of the drug, the largest federal criminal drug-company settlement to date.
Information that is finally making its way into the mainstream media is that type 2 diabetes is a lifestyle and diet issue that can be reversed without drugs. This information has been known for years, however, among those in the alternative health crowd. Consider these testimonials (s Continue reading

Study Links Vaccine Induced Immune Overload to Autism, Diabetes, Obesity

Study Links Vaccine Induced Immune Overload to Autism, Diabetes, Obesity

A new vaccine study published in Molecular and Genetic Medicine is bringing to the forefront the disturbing connection between the dramatic expansion in the quantity of routine childhood vaccines administered and a corresponding increase in inflammation-associated disorders.
Titled, "Review of Vaccine Induced Immune Overload and the Resulting Epidemics of Type 1 Diabetes and Metabolic Syndrome, Emphasis on Explaining the Recent Accelerations in the Risk of Prediabetes and other Immune Mediated Diseases," the study argues that vaccine-induced immune overload is a driving factor in a number of rapidly accelerating childhood epidemics including:
Autism
Type 1 diabetes
Asthma
Food allergies
Many autoimmune diseases
Obesity
Type 2 diabetes
Non-alcoholic fatty liver disease (NAFL)
Metabolic disease.
The paper sought to provide a theory of vaccine induced immune overload to explain many observations about the changes in the epidemics. The fundamental problem, according to the study, is that vaccinology assumes a 'one size fits all' approach that results in the majority of the vaccine recipients having overstimulated immune systems:
"One major problem with vaccines is the concept of one size fits all. Package inserts of almost all vaccines recommend a dose based on age. In order for a vaccine to be a commercial success it is expected to induce a protective immune response in well over 90% of children. In order for this to happen a dose, based on age, must stimulate a protective immune response in those with the weakest immune system. In the process of doing this, the other 90% or m Continue reading

No more pages to load

Popular Articles

Related Articles